Hillengaß, J., Ho, A. D., Goldschmidt, H., Waldherr, R., & Möhler, T. (2008). Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitis. International journal of hematology, 88(4), . https://doi.org/10.1007/s12185-008-0177-1
Chicago Style (17th ed.) CitationHillengaß, Jens, Anthony Dick Ho, Hartmut Goldschmidt, Rüdiger Waldherr, and Thomas Möhler. "Clinical Evidence for Immunomodulation Induced by High-dose Melphalan and Autologous Blood Stem Cell Transplantation as Cause for Complete Clinical Remission of Multiple Myeloma-associated Cryoglobulin-vasculitis." International Journal of Hematology 88, no. 4 (2008). https://doi.org/10.1007/s12185-008-0177-1.
MLA (9th ed.) CitationHillengaß, Jens, et al. "Clinical Evidence for Immunomodulation Induced by High-dose Melphalan and Autologous Blood Stem Cell Transplantation as Cause for Complete Clinical Remission of Multiple Myeloma-associated Cryoglobulin-vasculitis." International Journal of Hematology, vol. 88, no. 4, 2008, https://doi.org/10.1007/s12185-008-0177-1.